Arkolith/Insider Trading/AYTU/Form 4/A

Disbrow Joshua R.

Chief Executive Officer, DirectorAYTU BIOPHARMA, INC (AYTU) · full profile →Form 4/A · filed Nov 28, 2022
Net Buying
Open-Market Buys
$53K
Open-Market Sells
$0
Net Open-Market Flow
$53K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2022Buy(P)222K$0.24$53K1.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001567619-22-020922) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML